APO RESEARCH · REPORT
Zika Virus
Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.
Product & engineering
Understand the product.
Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.
Selected research
Industry Research
Zika Virus Industry Research Report 2026
Market perspective
Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.
Global Zika Virus key players include Chembio, Quest Diagnostics, ARUP Laboratories, Luminex Corporation, Simens, etc. Global top five manufacturers hold a share about 55%. North Amercia is the largest market, with a share about 45%, followed by Europe, with a share about 30 percent. In terms of product, Molecular Test is the largest segment, with a share about 90%. And in terms of application, the largest application is Diagnostic Centers, followed by Hospitals, Pathology Labs.
Report Scope
Read the full market overview
This report quantifies the global Zika Virus market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Zika Virus Market by Company
Bharat Biotech
Inovio Pharmaceuticals and GeneOne Life Sciences
Intrexon
Cerus
Sanofi
NewLink Genetics
Immunovaccine
GlaxoSmithKline
Zika Virus Segment by Type
Molecular Test
Serologic Test
Zika Virus Segment by Application
Diagnostic Centers
Hospitals
Pathology Labs
Zika Virus Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Zika Virus market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Zika Virus and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Zika Virus.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Zika Virus manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Zika Virus by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Zika Virus in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Molecular Test
- Serologic Test
Applications
- Diagnostic Centers
- Hospitals
- Pathology Labs
Companies covered
- Bharat Biotech
- Inovio Pharmaceuticals and GeneOne Life Sciences
- Intrexon
- Cerus
- Sanofi
- NewLink Genetics
- Immunovaccine
- GlaxoSmithKline
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Zika Virus Market Size (2021-2032)
- 2.2.2 Global Zika Virus Sales (2021-2032)
- 2.2.3 Global Zika Virus Market Average Price (2021-2032)
- 2.3 Zika Virus by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Molecular Test
- 2.3.3 Serologic Test
- 2.4 Zika Virus by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Diagnostic Centers
- 2.4.3 Hospitals
- 2.4.4 Pathology Labs
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Zika Virus Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Zika Virus Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Zika Virus Revenue of Manufacturers (2021-2026)
- 3.4 Global Zika Virus Average Price by Manufacturers (2021-2026)
- 3.5 Global Zika Virus Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Zika Virus, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Zika Virus, Product Type & Application
- 3.8 Global Manufacturers of Zika Virus, Established Date
- 3.9 Global Zika Virus Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Bharat Biotech
- 4.1.1 Bharat Biotech Company Information
- 4.1.2 Bharat Biotech Business Overview
- 4.1.3 Bharat Biotech Zika Virus Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Bharat Biotech Zika Virus Product Portfolio
- 4.1.5 Bharat Biotech Recent Developments
- 4.2 Inovio Pharmaceuticals and GeneOne Life Sciences
- 4.2.1 Inovio Pharmaceuticals and GeneOne Life Sciences Company Information
- 4.2.2 Inovio Pharmaceuticals and GeneOne Life Sciences Business Overview
- 4.2.3 Inovio Pharmaceuticals and GeneOne Life Sciences Zika Virus Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Inovio Pharmaceuticals and GeneOne Life Sciences Zika Virus Product Portfolio
- 4.2.5 Inovio Pharmaceuticals and GeneOne Life Sciences Recent Developments
- 4.3 Intrexon
- 4.3.1 Intrexon Company Information
- 4.3.2 Intrexon Business Overview
- 4.3.3 Intrexon Zika Virus Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Intrexon Zika Virus Product Portfolio
- 4.3.5 Intrexon Recent Developments
- 4.4 Cerus
- 4.4.1 Cerus Company Information
- 4.4.2 Cerus Business Overview
- 4.4.3 Cerus Zika Virus Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Cerus Zika Virus Product Portfolio
- 4.4.5 Cerus Recent Developments
- 4.5 Sanofi
- 4.5.1 Sanofi Company Information
- 4.5.2 Sanofi Business Overview
- 4.5.3 Sanofi Zika Virus Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sanofi Zika Virus Product Portfolio
- 4.5.5 Sanofi Recent Developments
- 4.6 NewLink Genetics
- 4.6.1 NewLink Genetics Company Information
- 4.6.2 NewLink Genetics Business Overview
- 4.6.3 NewLink Genetics Zika Virus Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 NewLink Genetics Zika Virus Product Portfolio
- 4.6.5 NewLink Genetics Recent Developments
- 4.7 Immunovaccine
- 4.7.1 Immunovaccine Company Information
- 4.7.2 Immunovaccine Business Overview
- 4.7.3 Immunovaccine Zika Virus Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Immunovaccine Zika Virus Product Portfolio
- 4.7.5 Immunovaccine Recent Developments
- 4.8 GlaxoSmithKline
- 4.8.1 GlaxoSmithKline Company Information
- 4.8.2 GlaxoSmithKline Business Overview
- 4.8.3 GlaxoSmithKline Zika Virus Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 GlaxoSmithKline Zika Virus Product Portfolio
- 4.8.5 GlaxoSmithKline Recent Developments
5 Global Zika Virus Market Scenario by Region
- 5.1 Global Zika Virus Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Zika Virus Sales by Region: 2021-2032
- 5.2.1 Global Zika Virus Sales by Region: 2021-2026
- 5.2.2 Global Zika Virus Sales by Region: 2027-2032
- 5.3 Global Zika Virus Revenue by Region: 2021-2032
- 5.3.1 Global Zika Virus Revenue by Region: 2021-2026
- 5.3.2 Global Zika Virus Revenue by Region: 2027-2032
- 5.4 North America Zika Virus Market Facts & Figures by Country
- 5.4.1 North America Zika Virus Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Zika Virus Sales by Country (2021-2032)
- 5.4.3 North America Zika Virus Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Zika Virus Market Facts & Figures by Country
- 5.5.1 Europe Zika Virus Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Zika Virus Sales by Country (2021-2032)
- 5.5.3 Europe Zika Virus Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Zika Virus Market Facts & Figures by Country
- 5.6.1 Asia Pacific Zika Virus Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Zika Virus Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Zika Virus Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Zika Virus Market Facts & Figures by Country
- 5.7.1 South America Zika Virus Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Zika Virus Sales by Country (2021-2032)
- 5.7.3 South America Zika Virus Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Zika Virus Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Zika Virus Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Zika Virus Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Zika Virus Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Zika Virus Sales by Type (2021-2032)
- 6.1.1 Global Zika Virus Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Zika Virus Sales Market Share by Type (2021-2032)
- 6.2 Global Zika Virus Revenue by Type (2021-2032)
- 6.2.1 Global Zika Virus Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Zika Virus Revenue Market Share by Type (2021-2032)
- 6.3 Global Zika Virus Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Zika Virus Sales by Application (2021-2032)
- 7.1.1 Global Zika Virus Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Zika Virus Sales Market Share by Application (2021-2032)
- 7.2 Global Zika Virus Revenue by Application (2021-2032)
- 7.2.1 Global Zika Virus Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Zika Virus Revenue Market Share by Application (2021-2032)
- 7.3 Global Zika Virus Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Zika Virus Value Chain Analysis
- 8.1.1 Zika Virus Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Zika Virus Production Mode & Process
- 8.2 Zika Virus Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Zika Virus Distributors
- 8.2.3 Zika Virus Customers
9 Global Zika Virus Analyzing Market Dynamics
- 9.1 Zika Virus Industry Trends
- 9.2 Zika Virus Industry Drivers
- 9.3 Zika Virus Industry Opportunities and Challenges
- 9.4 Zika Virus Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst